Media Coverage Fighting Neurodegeneration with Tau Tangle Blocking: Oligomerix CEO James Moe Explains November 24, 2020 By vera This article is sourced from an external publication. Read the original → ← PreviousOligomerix to Present at Clinical Trials on Alzheimer’s Disease Conference & Life Sciences SummitNext →Oligomerix to Present at Upcoming Life Sciences Conferences
